{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T07:33:58Z","timestamp":1778139238615,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81672940"],"award-info":[{"award-number":["81672940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Clinical Research Physician Program of Tongji Medical College, Huazhong University of Science and Technology","award":["5001530053"],"award-info":[{"award-number":["5001530053"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The heart transplantation is the most important treatment for patients with end-stage severe heart disease who failed to conventional therapy. Post-transplant lymphoproliferative disorder is the second most common malignancy in heart transplant recipients. However, primary central nervous system lymphoma (PCNSL) after heart transplantation is an extremely rare condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients concerns:<\/jats:title>\n            <jats:p>This report described a 53-year-old male who was diagnosed as PCNSL 17 months after heart transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was admitted to the local hospital presenting with dizziness, headache, and reduced left-sided power and sensation for 1 week. He had a medical history of heart transplantation because of the dilated cardiomyopathy 17 months ago and had a 17-month history of immunosuppressive therapy with tacrolimus. A computed tomography scan of the brain revealed a bulky mass in the right temporal lobe. The emergency intracranial mass resection and cerebral decompression were performed in our hospital. The histopathology of the brain lesions showed diffuse large B-cell lymphoma. A further <jats:sup>18<\/jats:sup>FDG positron emission tomography-computed tomography scan of the whole body showed no significantly increased metabolic activity in other regions. The final diagnosis of this patient was PCNSL after heart transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Given the poor health condition, with the patient's consent, the whole brain radiotherapy was performed with supportive care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The disease deteriorated rapidly during the period of receiving radiotherapy, and he died within 2 months from the diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>PCNSL after heart transplantation is an extremely rare phenomenon with extremely poor prognosis. We should pay close attention to the heart recipients, especially when the patients present with neurological symptoms and signs. The available treatment options for PCNS-post-transplant lymphoproliferative disorder include the reduction of immunosuppressive drugs, immune-chemotherapy, operation, radiotherapy. However, individual treatments for heart transplant recipients with PCNSL should be based on the performance status and tolerance to treatment, combined with the doctor's experience and supportive care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021844","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:00:10Z","timestamp":1598461210000},"page":"e21844","source":"Crossref","is-referenced-by-count":6,"title":["Primary central nervous system lymphoma after heart transplantation"],"prefix":"10.1097","volume":"99","author":[{"given":"Fang","family":"Zhu","sequence":"first","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhui","family":"Li","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Xiao","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxiong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2011.08.004","article-title":"The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report\u20132011","volume":"30","author":"Christie","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1600-6143.2008.02196.x","article-title":"Malignancy after heart transplantation: incidence, prognosis and risk factors","volume":"8","author":"Crespo-Leiro","year":"2008","journal-title":"Am J Transplant"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/0003-4975(95)00782-2","article-title":"De novo solid malignancies after cardiac transplantation","volume":"60","author":"Goldstein","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.amjcard.2008.10.026","article-title":"Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population","volume":"103","author":"Kellerman","year":"2009","journal-title":"Am J Cardiol"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1540-8191.2009.00858.x","article-title":"Malignancy after heart transplantation: analysis of 24-year experience at a single center","volume":"24","author":"Yagdi","year":"2009","journal-title":"J Cardiac Surg"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"R7-20230915","first-page":"1271","article-title":"The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town","author":"Barnard","year":"1967","journal-title":"S Afr Med JV 41"},{"key":"R8-20230915","first-page":"12","article-title":"Malignancies after heart transplant","volume":"14","author":"Lateef","year":"2016","journal-title":"Exp Clin Transpl"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1010-7940(01)00674-1","article-title":"Neoplastic disease after heart transplantation: single center experience","volume":"19","author":"Rinaldi","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/0284186X.2013.844853","article-title":"A population-based study of 135 lymphomas after solid organ transplantation: the role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival","volume":"53","author":"Kinch","year":"2014","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transpl"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-200023020-00002","article-title":"Post-transplant malignancy: the role of immunosuppression","volume":"23","author":"Penn","year":"2000","journal-title":"Drug Safety"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archneur.1970.00480210036004","article-title":"Cerebral neoplasms associated with renal transplantation","volume":"22","author":"Schneck","year":"1970","journal-title":"Arch Neurol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/ajt.12211","article-title":"Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era","volume":"13","author":"Evens","year":"2013","journal-title":"Am J Transpl"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/ajt.14465","article-title":"Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients","volume":"18","author":"Mahale","year":"2018","journal-title":"Am J Transpl"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/imj.12735","article-title":"Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation","volume":"45","author":"Gifford","year":"2015","journal-title":"Internal Med J"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaapos.2017.10.016","article-title":"Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant","volume":"22","author":"Bata","year":"2018","journal-title":"J AAPOS"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/N82CTQ1J0XEVEFQB","article-title":"Primary central nervous system posttransplant lymphoproliferative disorders","volume":"121","author":"Castellano-Sanchez","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0161-6420(92)31867-6","article-title":"Intraocular and central nervous system lymphoma in a cardiac transplant recipient","volume":"99","author":"Johnson","year":"1992","journal-title":"Ophthalmology"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3324\/haematol.10595","article-title":"CHOP-21 for the treatment of post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation","volume":"92","author":"Choquet","year":"2007","journal-title":"Haematologica"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/ajh.24204","article-title":"Rituximab with high-dose methotrexate in primary central nervous system lymphoma","volume":"90","author":"Kansara","year":"2015","journal-title":"Am J Hematol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1600-6143.2009.02598.x","article-title":"Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate","volume":"9","author":"Nabors","year":"2009","journal-title":"Am J Transpl"},{"key":"R24-20230915","first-page":"1225\u20135","article-title":"Intraocular lymphoma after cardiac transplantation: magnetic resonance imaging findings","volume":"14","author":"Kim","year":"2013","journal-title":"Korean J Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:54:07Z","timestamp":1694825647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021844"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":24,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021844","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]}}}